Serum thymidine kinase 1 activity (TKa) levels and progression-free survival (PFS) in patients (pts) with hormone receptor positive (HR+) HER2-negative metastatic breast cancer (MBC) on palbociclib (Pb) and endocrine therapy (ET)Ciara C. O'Sullivan,Jun He,Jason Sinnwell,Vera J. Suman,Krishna R. Kalari,Peter T. Vedell,Ann M. Moyer,Xiaojia Tang,Kevin J. Thompson, Abe Eyman Casey,Alvaro Moreno-Aspitia,Donald W. Northfelt,Minetta C. Liu,Tufia C. Haddad,Saranya Chumsri,Brendan McMenomy,Prema Peethambaram,Kathryn J. Ruddy,Karthik V. Giridhar,Roberto A. Leon-Ferre,Mattias Bergqvist,Adrian Nordmark,Richard M. Weinshilboum,Liewei Wang,Matthew P. GoetzCANCER RESEARCH（2022）引用 0|浏览20暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
